Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
<h4>Background</h4>The National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available commercially (EarlyCDT®-Lung) to a...
Guardado en:
Autores principales: | Isabel K Macdonald, Andrea Murray, Graham F Healey, Celine B Parsy-Kowalska, Jared Allen, Jane McElveen, Chris Robertson, Herbert F Sewell, Caroline J Chapman, John F R Robertson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8438960788f54e9abee9c438965f1446 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and validation of a high throughput system for discovery of antigens for autoantibody detection.
por: Isabel K Macdonald, et al.
Publicado: (2012) -
Cdt1 stabilizes an open MCM ring for helicase loading
por: Jordi Frigola, et al.
Publicado: (2017) -
The prognostic significance of Cdc6 and Cdt1 in breast cancer
por: Ravikiran Mahadevappa, et al.
Publicado: (2017) -
Stabilisation of half MCM ring by Cdt1 during DNA insertion
por: Marina Guerrero-Puigdevall, et al.
Publicado: (2021) -
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Chenhui Cai, et al.
Publicado: (2021)